185 related articles for article (PubMed ID: 27855463)
1. Association of Maternal Obesity with Child Cerebral Palsy or Death.
McPherson JA; Smid MC; Smiley S; Stamilio DM
Am J Perinatol; 2017 May; 34(6):563-567. PubMed ID: 27855463
[No Abstract] [Full Text] [Related]
2. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
3. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
Faucett AM; Metz TD; DeWitt PE; Gibbs RS
Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047
[TBL] [Abstract][Full Text] [Related]
4. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes.
McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM
Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275
[TBL] [Abstract][Full Text] [Related]
5. Maternal obesity is associated with chorioamnionitis and earlier indicated preterm delivery among expectantly managed women with preterm premature rupture of membranes.
Hadley EE; Discacciati A; Costantine MM; Munn MB; Pacheco LD; Saade GR; Chiossi G
J Matern Fetal Neonatal Med; 2019 Jan; 32(2):271-278. PubMed ID: 28936902
[TBL] [Abstract][Full Text] [Related]
6. Maternal side effects & fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial.
Vilchez G; Dai J; Lagos M; Sokol RJ
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):178-183. PubMed ID: 28056569
[TBL] [Abstract][Full Text] [Related]
7. Association Between Maternal Body Mass Index in Early Pregnancy and Incidence of Cerebral Palsy.
Villamor E; Tedroff K; Peterson M; Johansson S; Neovius M; Petersson G; Cnattingius S
JAMA; 2017 Mar; 317(9):925-936. PubMed ID: 28267854
[TBL] [Abstract][Full Text] [Related]
8. Prenatal Tobacco Exposure and Childhood Neurodevelopment among Infants Born Prematurely.
Robbins LS; Blanchard CT; Sinkey RG; Harris SL; Tita AT; Harper LM
Am J Perinatol; 2021 Feb; 38(3):218-223. PubMed ID: 32862421
[TBL] [Abstract][Full Text] [Related]
9. Maternal and perinatal outcomes of extreme obesity in pregnancy.
Crane JM; Murphy P; Burrage L; Hutchens D
J Obstet Gynaecol Can; 2013 Jul; 35(7):606-611. PubMed ID: 23876637
[TBL] [Abstract][Full Text] [Related]
10. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
11. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
12. The combined effects of maternal depression and excess weight on neonatal outcomes.
McDonald SD; McKinney B; Foster G; Taylor V; Lutsiv O; Pullenayegum E
Int J Obes (Lond); 2015 Jul; 39(7):1033-40. PubMed ID: 25817069
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of a randomized clinical perinatal trial: maternal magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hauth JC; Nelson KG; Goldenberg RL
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):701-5. PubMed ID: 8828437
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy complications associated with the co-prevalence of excess maternal weight and depression.
Lutsiv O; McKinney B; Foster G; Taylor VH; Pullenayegum E; McDonald SD
Int J Obes (Lond); 2015 Dec; 39(12):1710-6. PubMed ID: 26095247
[TBL] [Abstract][Full Text] [Related]
15. [Maternal pre-pregnancy obesity and the risk of preterm birth: a systematic overview of cohort studies with meta-analysis].
Kanadys WM; Leszczyńska-Gorzelak B; Jedrych M; Oleszczuk J
Ginekol Pol; 2012 Apr; 83(4):270-9. PubMed ID: 22712259
[TBL] [Abstract][Full Text] [Related]
16. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
17. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
18. Maternal obesity and risk of preterm delivery.
Cnattingius S; Villamor E; Johansson S; Edstedt Bonamy AK; Persson M; Wikström AK; Granath F
JAMA; 2013 Jun; 309(22):2362-70. PubMed ID: 23757084
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
Clark EAS; Weiner SJ; Rouse DJ; Mercer BM; Reddy UM; Iams JD; Wapner RJ; Sorokin Y; Malone FD; O'Sullivan MJ; Peaceman AM; Hankins GDV; Dudley DJ; Caritis SN;
Am J Perinatol; 2018 Aug; 35(10):1012-1022. PubMed ID: 29510423
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Cerebral Palsy Severity Between 2 Eras of Antenatal Magnesium Use.
Stetson BT; Buhimschi CS; Kellert BA; Hay K; Buhimschi IA; Maitre NL
JAMA Pediatr; 2019 Feb; 173(2):188-190. PubMed ID: 30508016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
